# Multimodal Managements for Metastatic Pancreatic Cancer.

> **NCT06967233** · — · COMPLETED · sponsor: **Zhejiang University** · enrollment: 360 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **OTHER:** Multimodal treatment

## Key facts

- **NCT ID:** NCT06967233
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-04-01
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967233, "Multimodal Managements for Metastatic Pancreatic Cancer.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06967233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*